NCT01807026View on ClinicalTrials.gov

A Study of LY2886721 in Healthy Participants and Participants Diagnosed With Alzheimer's Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Alzheimer DiseaseHealthy Volunteers
Interventions
DRUG

LY2886721

DRUG

Placebo

Trial Locations (1)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Salt Lake City

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT01807026 - A Study of LY2886721 in Healthy Participants and Participants Diagnosed With Alzheimer's Disease | Biotech Hunter | Biotech Hunter